[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100477346":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":12,"centralContacts":17,"locations":26,"responsibleParty":44,"collaborators":46,"id":64,"slug":65,"hasResults":66,"nctId":67,"briefTitle":68,"officialTitle":68,"acronym":69,"eligibilityCriteria":70,"healthyVolunteers":66,"sex":71,"minAge":72,"maxAge":10,"enrollmentInfo":73,"targetDuration":76,"studyType":77,"phases":10,"briefSummary":78,"conditions":79,"keywords":84,"overallStatus":29,"whyStopped":10,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":90,"completionDateStruct":92,"leadSponsor":94,"locationsCount":95},{"fullName":5,"class":6},"State Scientific Centre of Coloproctology, Russian Federation","OTHER_GOV",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Patients with colorectal cancer",null,"Patients with colon adenocarcinoma who have not previously received antitumor treatment (chemo\u002Fradiation therapy) for a currently detected tumor",[13],{"name":14,"affiliation":15,"role":16},"Alexey Tsukanov, PhD","Head of the Department of Laboratory Genetics","PRINCIPAL_INVESTIGATOR",[18,23],{"name":19,"role":20,"phone":21,"phoneExt":10,"email":22},"Dmitrii Semenov, PhD","CONTACT","+7 (985) 2632870","dr.semenov@inbox.ru",{"name":14,"role":20,"phone":24,"phoneExt":10,"email":25},"+7 (916) 7563957","tsukanov81@rambler.ru",[27],{"facility":28,"status":29,"city":30,"state":10,"zip":31,"country":32,"countryCode":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":40},"State Scientific Centre of Coloproctology","RECRUITING","Moscow","123423","Russia","RU",{"type":35,"coordinates":36},"Point",[37,38],37.61781,55.75204,{"lat":38,"lon":37},[41],{"name":42,"role":20,"phone":43,"phoneExt":10,"email":25},"Alexey Tsukanov, Phd","+79167563957",{"type":45,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[47,50,52,54,56,58,60,62],{"name":48,"class":49},"The Loginov MCSC MHD","UNKNOWN",{"name":51,"class":49},"Pirogov National Medical and Surgical Center",{"name":53,"class":49},"Moscow City Oncological Hospital No. 62 MHD",{"name":55,"class":49},"City Clinical Oncological Hospital No. 1 MHD",{"name":57,"class":6},"Moscow Multidisciplinary Clinical Center \"Kommunarka\"",{"name":59,"class":49},"D.D. Pletnev City Clinical Hospital MHD",{"name":61,"class":49},"Botkin Hospital MHD",{"name":63,"class":49},"Clinic K+31","100477346","prospective-multicenter-registry-study-to-assess-the-frequency-of-lynch-syndrome-among-patients-with-colorectal-cancer-100477346",false,"NCT05495776","Prospective Multicenter Registry Study to Assess the Frequency of Lynch Syndrome Among Patients With Colorectal Cancer","MSIRus22","Inclusion Criteria:\n\n* Provision of written informed consent;\n* Patients with histologically verified colon adenocarcinoma or patients with histologically verified synchronous neoplasms who have not previously received treatment for a second tumor;\n* Age ≥ 18 years;\n* Absence of antitumor treatment for a real tumor (it is allowed to include patients who have a history of antitumor treatment for other malignant tumors, if the period after treatment is more than 12 months).\n* The ability of the patient, according to the Researcher, to fulfill the requirements of the Protocol;\n\nExclusion Criteria:\n\n\\- Patients receiving chemotherapy or radiotherapy for colon cancer at the time of screening","ALL","18 Years",{"count":74,"type":75},2500,"ESTIMATED","5 Years","OBSERVATIONAL","Prospective multicenter registry study to assess the frequency of Lynch syndrome among patients with colorectal cancer in Russia",[80,81,82,83],"Colorectal Cancer","Lynch Syndrome","Hereditary Colorectal Cancer","MSI",[80,81,82,83,85],"Frequency","2022-10-24",{"date":88,"type":89},"2022-10-25","ACTUAL",{"date":91,"type":89},"2022-08-01",{"date":93,"type":75},"2028-12-31",{"name":5,"class":6},1]